Table 1 Baseline characteristics of patients with sarcoma
From: Homeoprotein SIX1 compromises antitumor immunity through TGF-β-mediated regulation of collagens
Parameter | Subtype | Number of patients (%) |
|---|---|---|
Treatment outcome | Complete response | 126 (48.4) |
(Chemotherapy) | Partial response | 2 (0.7) |
Progressive disease | 59 (22.6) | |
Stable disease | 12 (4.6) | |
Unknown | 61 (23.4) | |
Age | >60 | 130 (50) |
≤60 | 130 (50) | |
Sex | Female | 142 (54.6) |
Male | 118 (45.3) | |
Group | High SIX1 expression | 130 (50) |
Low SIX1 expression | 130 (50) |
